Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 74 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8278299

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  2. US 8278306

    C-met protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  3. US 8278297

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  4. US 8278450

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  5. US 8273746

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  6. US 8273709

    Triazole-containing macrocyclic HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  7. US 8268811

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  8. US 8268776

    Macrocylic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  9. US 8268873

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  10. US 8269012

    Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  11. US 8268999

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  12. US 8269013

    Substituted pyrazole inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  13. US 8268829

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  14. US 8268818

    Inhibitors of C-MET and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  15. US 8263657

    Inhibitors against the production and release of inflammatory cytokines

    Institute of Medicinal Molecular Design, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  16. US 8263651

    Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors

    The Regents of the University of California · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  17. US 8263776

    Inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  18. US 8263549

    C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  19. US 8257915

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  20. US 8258308

    Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

    Laboratories Almirall, S.A. · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  21. US 8252923

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  22. US 8252787

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  23. US 8247563

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  24. US 8247421

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted